< The deleted user >
0
All posts from < The deleted user >
Mayun in Mayun - 交易者个人网站,

投行观点:Baird将BioMarin Pharmaceutical评级下调至中性,目标价从125美元上调至133美元

以上为即时重要消息提示,路透中文快讯将暂不做进一步报导。